Germany· DE-A57-b343c1f512fdfbef
Vasosan P
A medicinal product containing anhydrous cholestyramine, registered in Germany by Agraria Pharma Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Anhydrous Cholestyramine
- Manufacturer
- Agraria Pharma Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Anhydrous cholestyramine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCholestyraminePar Health USA, LLC
- United KingdomColestyramine 10% creamSpecial Order
- NorwayColestyramin orifarmOrifarm Generics A/S
- NetherlandsColestyramine suikervrij 4 g Focus, poeder voor orale suspensieFocus Care Pharmaceuticals B.V.
- CanadaCHOLESTYRAMINE-ODANODAN LABORATORIES LTD
- SwedenKolestyramin Alternova 4 g Pulver till oral suspension, dospåseAlternova A/S
- CzechiaRESINCOLESTIRAMINA
- SpainEFENSOL 3 g POLVO PARA SUSPENSION ORALFaes Farma S.A.
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Austria · Quantalan Zuckerfrei
- Belgium · Questran
- Cyprus · Resincolestiramina
- Denmark · Colestyramin Orifarm
- Spain · Efensol, Resincolestiramina
- Finland · Questran
- France · Questran
- United Kingdom (Northern Ireland) · Colestyramine Light Laboratorios Rubió, Colestyramine Neon Healthcare
- Hungary · Cholestyramine
- Ireland · Questran
- Italy · Questran
- Luxembourg · Questran
- Netherlands · Colestyramine Suikervrij Focus, Questran
- Norway · Questran, Questran Loc
- Portugal · Quantalan
- Sweden · Kolestyramin Alternova, Questran
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/82a3e8c9-8e7a-4e47-b2f7-783595498da1 GET /v1/drugs/82a3e8c9-8e7a-4e47-b2f7-783595498da1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Oral Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Anhydrous Cholestyramine",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about anhydrous cholestyramine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.